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In this proof-of-principle study, we established and implemented a cross-modality imaging (CMI) pipeline
to characterize and compare bisphosphonate (BIS)-treated jawbones of Sprague-Dawley rats after tooth
extraction after physical therapies (photobiomodulation and extracorporeal shockwave therapy (PBMT
and ESWT)). We showcase the feasibility of such a CMI approach and its compatibility across imaging
modalities to probe the same region of interest (ROI) of the same jawbone. Jawbones were imaged
in toto in 3D using micro-Computed Tomography to identify ROIs for subsequent sequential 2D analysis
using well-established technologies such as Atomic Force Microscopy and Scanning Electron
Microscopy, and recent imaging approaches in biomedical settings, such as micro-X-Ray Fluorescence
Spectroscopy. By combining these four modalities, multiscale information on the morphology, topogra-
phy, mechanical stiffness (Young’s modulus), and calcium, zinc and phosphorus concentrations of the
bone was collected. Based on the CMI pipeline, we characterized and compared the jawbones of a pre-
viously published clinically relevant rat model of BIS-related osteonecrosis of the jawbone (BRONJ)
before and after treatment with BISs, PBMT and ESWT. While we did not find that physical therapies
altered the mechanical and elemental jawbone parameters with significance (probably due to the small
sample size of only up to 5 samples per group), both ESWT and PBMT reduced pore thicknesses and
bone-to-enamel distances significantly compared to the controls. Although focused on BIS-treated jaw-
bones, the established CMI platform can be beneficial in the study of bone-related diseases in general
(such as osteoarthritis or -porosis) to acquire complementary hallmarks and better characterize disease
status and alleviation potentials.
Introduction
Bisphosphonates (BISs) are widely used for the treatment of
rheumatologic and oncological diseases with bone metastasis
and are commonly administered in osteolytic conditions.1 BISs
are pyrophosphate analogs in which oxygen is replaced by a
carbon atom, resulting in a backbone P–C–P which is stable
against enzymes with hydrolytic activity. Although BISs have a
similar core structure, they also contain two side-chains or
groups, R1 and R2, attached to the central carbon atom. All
the recently developed BISs contain a hydroxy side-group at
position R1, increasing their binding to bone. Differences in
the physicochemical and biological properties of BISs are due
to the differences in the R2 side-group, where the presence of
nitrogen and its orientation within the R2 side-chain can influ-
ence their overall potency.2,3
BISs are generally classified as first (e.g., etidronate and clo-
dronate), second (e.g., alendronate and pamidronate) or third
generation (e.g., zoledronate, ZOL (Fig. 1)). The main indi-
cations for ZOL are hypercalcemia of malignancy, multiple
myeloma and bone metastases from solid tumors. The taxon-
omy of BISs based on their chemical structure, such as their
nitrogen content, is clinically more relevant as more severe
side-effects (i.e. BIS-related osteonecrosis of the jaw, BRONJ)
have been attributed to BISs containing nitrogen.1,4 The main
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therapeutic effect of BISs is linked to the inhibition of the
activity and apoptosis induction of osteoclasts,2,5 which leads
to the inhibition of bone resorption and a reduction of bone
turnover5 and, hence, in an increase in mineral density.6
Interestingly, the mechanism of action shows differences as a
function of the nitrogen content. Non-nitrogen-containing
BISs (etidronate and clodronate) are intracellularly incorpor-
ated, and their accumulation leads to osteoclast apoptosis by
inhibiting ATP-dependent enzymes.2,3 Inhibition of farnesyl
diphosphate synthase is one of the modes of action of nitrogen
containing BISs, leading to decreased functional activity and
apoptosis of osteoclasts.7
Although BIS treatment undoubtedly improves the quality
of life of the patients,8 together with other antiresorptive9 and
antiangiogenic drugs,10 BISs may induce necrosis of the oral
bones (BRONJ). This occurs mainly after invasive dental pro-
cedures, e.g., tooth extraction or a periodontal disorder,1 with
an increased incidence particularly after the use of third-gene-
ration BISs (e.g. ZOL).5 The exact pathomechanism is not yet
fully understood, but characteristics of drug administration
(oral vs. intravenous (i.v.), non-/nitrogen-containing BIS, dur-
ation of the therapy), indication of BIS administration (osteo-
porosis, oncological reason), co-morbidities, concomitant use
of other drugs (corticosteroids or chemotherapeutic drugs),
poor oral hygiene or genetic factors may be considered.11
Osteonecrosis develops typically several years after an invasive
dental procedure, which may be explained by the long half-
lives of these medications.5 In our previous study,12 BIS treat-
ment was associated with mucosal healing disorders and
some degree of discontinuity of the cortical and spongious
bone regions in the mandible in a clinically relevant rat model
of BRONJ.
Extracorporeal shock wave (ESWT) therapy has been well
established in the field of orthopedics13,14 for many years as a
safe and non-invasive treatment option for indications like
non-union fractures, chronic tendinopathies15 or plantar fas-
ciitis. Cell regeneration and pain release were main effects
achieved through ESWT.16,17 In recent years, the field of appli-
cations has become increasingly broader and now includes
investigations into soft tissue18 and nerve19,20 regeneration as
well as urology, trans-cranial and dental applications. In the
dental field, for instance, ESWT applications have shown
decreased tooth movement in rats in conjunction with
increased osteoblast and osteoclast activities.21 Furthermore,
safety of dental ESWT was shown in human patients.22,23 As
such, the treatment modality was included in the experimental
setup to study its effects on BIS-treated samples. Although
ESWT is frequently used in medical treatments, the underlying
effects are not yet known in detail.24 ESWTs induce different
chemical, mechanical and thermal effects in tissue. Thermal
effects are created through interactions between compression
and decompression and are proven to have no clinical rele-
vance. The occurrence of free radicals is probable but also
without relevance.25 Cavitation through pressure change and
occurrence of small gas-filled bubbles leads to jet streams
(local high-speed liquid streams) in tissue. The effect of these
streams is also not understood in detail but seems to be of
high clinical relevance.25,26 In brief, shockwave treatment con-
sists of a series of mechanical pressure waves that are focused
via an applicator that may be electrohydraulic, electromagnetic
or piezo-electric.
Photobiomodulation therapy (PBMT) uses photons at non-
thermal irradiance to promote biological activity. In general,
PBMT makes use of light with a wavelength spectrum of
450–1200 nm (depending on the desired penetration depth)
with low energy density (up to 1 W cm−2). While lasers have
been the gold standard as light sources, nowadays devices
based on LED technology have come into the focus of
research. PBM radiation initiates photochemical, photoelec-
tric and photoenergetic reactions that affect the treated
tissues by altering the metabolic functions of the cells and
modulating biological processes. During the last few decades,
numerous studies demonstrated the beneficial effects of light
in the form of PBM for the treatment of various pathologies –
although the exact cellular mechanisms responsible for the
positive effects are not fully understood yet. Beside the pro-
motion of wound healing and angiogenesis27 and the
reduction of inflammatory reactions,28 the enhancement of
bone formation represents an important field of application
for PBMT. PBMT of bone tissue seems to improve the results
of fracture repair, periodontal tissue, implant osseointegra-
tion and bone reconstruction with or without biomaterials
(reviewed in ref. 29).
The appropriate management of BRONJ is still a challenge.
Since conventional treatments are not always satisfactory, the
use of adjuvant therapies is necessary. Recently, two case
Fig. 1 Chemical structure depiction of zoledronate. From National
Center for Biotechnology Information (2021). PubChem Compound
Summary for CID 68740, zoledronic acid. Retrieved April 13, 2021 from
https://pubchem.ncbi.nlm.nih.gov/compound/Zoledronic-acid.
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reports showed the efficacy of PBMT, however in combination
with antibiotics or platelet-rich plasma.30,31
A promising and novel approach to gain insights about the
hallmarks of bone diseases holistically is cross-modality
imaging (CMI). Currently, bioimaging is experiencing major
boosts: the resolution revolution in electron cryo-microscopy
(cryo-EM) led to an exponential increase in single particle
structures and is accompanied by a ‘volume revolution’ that
allows to scan big volumes at high resolution using for
example focused ion beams and scanning electron microscopy
(FIB/SEM). The same holds true for advanced light microscopy,
which routinely resolves subcellular structures both below the
diffraction limit (superresolution) and in thick tissue samples
with increased penetration depth (light sheet and multiphoton
microscopy). Spectroscopic imaging techniques are being used
increasingly to characterize biomedical samples biophysically,
assessing molecular (Mass Spectrometry Imaging, MSI),
elemental (micro-X-Ray Fluorescence Spectroscopy, µXRF) or
mechanical (Brillouin or Atomic Force Microscopy, AFM) infor-
mation. In addition, the frontiers of bioimaging are currently
being pushed towards the integration and correlation of these
modalities to tackle biomedical research questions holistically
and across multiple scales: CMI combines two or more comp-
lementary modalities that create a composite view of the
sample and allow to access structural, functional and biophysi-
cal parameters from exactly the same sample from a single
time point (Fig. 2). Novel CMI pipelines can bridge whole-
animal imaging and ex vivo biological microscopy to zoom in
from an intact sample to individual cells and combine
localized biophysical or chemical information with structural
and functional parameters.32,59 Examples of correlative
imaging pipelines that specifically unravel elemental 3D distri-
butions include the work of De Samber et al.57 and Gholap
et al.58 on the ecotoxicological model organism Daphnia
magna: the results of µXRF were fused and co-registered into a
morphological µCT 3D image,57 and element-to-tissue corre-
lation was obtained using µXRF and laser ablation-inductively
coupled plasma-mass spectrometry.58
In this study, we showcase the feasibility of a novel CMI
pipeline that comprises micro-Computed Tomography (µCT),
µXRF, AFM and SEM (Fig. 4) to characterize the morphology,
topography, mechanical stiffness and elemental concen-
trations of the jawbones of our clinically relevant rat model of
BRONJ before and after treatment with BISs, PBMT and ESWT.
We set up a workflow that was compatible across all imaging
modalities and allowed the characterization of the same
regions of interest (ROI) for each sample and technique
(compare Fig. 4). The combination of the imaging modalities
aimed at gaining morphological insights across length scales
(from µCT at an isotropic voxel size of about 20 µm to SEM at
sub-micrometer resolution) and complementing the morpho-
logical characterization by chemical (i.e., the elemental con-
centrations of calcium (Ca), phosphorus (P) and zinc (Zn)) and
mechanical imaging parameters (i.e., the Young’s modulus).
Comprehensive imaging of BIS-treated jawbones ideally
includes resolving the morphology at a (sub-)micrometer
resolution to visualize for example microfractures at high
resolution. Usually, for microscopy, penetration depth comes
at the expense of lateral resolution, and visualizing a large
volume of tissue at such high resolution is not possible
(Fig. 2). Due to the established CMI pipeline, we were able to
first visualize the entire intact jawbone in 3D at an isotropic
resolution of 17.2 µm using µCT and then select a region of
interest (ROI) that, after cutting of the bone, was scanned in
2D with increased lateral resolution of about 800 nm using
SEM – in addition to adding elemental and mechanical infor-
Fig. 2 Multiscale and holistic imaging: accessible information (A) and resolution (B) to CMI. Adapted from Walter et al.32 SXT (soft X-ray tomogra-
phy), HREM (high resolution episcopic microscopy), EM (electron microscopy), CT (computed tomography), OI (optical imaging including bio-
luminescence & fluorescence imaging), LSFM (light sheet fluorescence microscopy), MPM (multiphoton microscopy), confocal (microscopy), MRI
(magnetic resonance imaging), ultrasound, PAI (photoacoustic imaging), OCT (optical coherence tomography), XRF (X-ray fluorescence spec-
troscopy), AFM (atomic force microscopy), MSI (mass spec imaging), superresolution (microscopy such as STORM, PALM, STED), PET/SPECT (posi-
tron emission tomography/single photon emission computed tomography).
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mation using µXRF and AFM (see Fig. 4). So far, BIS-treated
bones have been characterized largely using imaging modal-
ities that reveal mainly structural parameters, and specific fea-
tures of osteonecrosis have mainly been studied indepen-
dently. This includes for example SEM to visualize osteocytic
lacunae, Volkmann’s or Haversian systems, immunofluores-
cence and histology to assess osteocyte necrosis, osteoclast
numbers or osteocalcin, and computed tomography to
measure bone sequestration and fragmentation.32 There are
only few studies that quantify and interrelate the effects of
BISs on both the (micro)architecture and (biophysical) tissue
properties of the jawbone. For example, BISs administered at
high doses were shown to arrest the osteoblast cell cycle and
to reduce the apatite crystal size, which may lead to altered
mechanical characteristics.32 Additionally, in rats, the onset of
BRONJ was shown to correlate with increased unrepaired crack
densities in the jawbone, which is likely to change its mechan-
ical integrity.33 While much of our understanding of BISs and
their role in osteonecrosis originates from preclinical studies
that involve a single imaging modality, it is desirable to charac-
terize the effects of BISs and a corresponding onset of BRONJ
in a broader context to develop therapeutic strategies. With the
established CMI pipeline, we aimed at showcasing the
feasibility of acquiring morphological, elemental and mechan-
ical parameters from within the same ROI of the same
jawbone using four complementary imaging modalities, and
comparing them before and after BIS treatment and physical




Twelve-week-old male Sprague-Dawley rats were treated with
ZOL (80 µg kg−1 i.v. once a week, over 9 weeks) (n = 16) or with
a saline vehicle instead of BIS (n = 3) (Fig. 3).12 At the end of
the third week of the protocol, the first and second molar
teeth on the right side were extracted from the mandible in all
of the BIS-treated animals under ketamine (25 mg kg−1 i.p.)
and xylazine (75 mg kg−1 i.p.) anesthesia. The teeth were
luxated with an 18G needle and the extraction was performed
with extraction forceps. The roots were also removed with a
dental drill under a Zeiss operating microscope (6× magnifi-
cation, Carl Zeiss GmbH, Jena, Germany).
In one group of the BIS-treated animals (n = 6), rats were
treated with local ESWT. An electrohydraulic applicator was
used to focus the pressure wave from a high voltage spark to
the target tissue after acoustic coupling. These focused
pressure waves are characterized by a very fast initial pressure
raise up to approximately 100 MPa within a few nanoseconds,
followed by an elongated negative (tensile) pressure wave of
lesser magnitude, providing a mechanic stimulus to the tissue.
Immediately after the tooth extraction, shock wave treatment
at 600 pulses at about 0.2 mJ mm−2 and 3 Hz were applied
using the electrohydraulic Derma-Gold®100 device connected
to a type OP155 applicator (Tissue Regeneration Technologies,
LLC, manufactured by MTS Europe GmbH, Stuttgart,
Germany). The applicator was placed directly on the skin
above the location of the tooth extraction during the
treatment.
In another BIS-treated group (n = 6), animals were locally
treated by PBMT (with the diode placed directly on the lateral
side of tooth extraction area) starting on the day of tooth
extraction, which was followed by 7 more treatments every
second day under light anesthesia with ketamine & xylazine
(see above). Illumination was performed at room temperature
for 90 s with a dose of 9 J cm−2 using a pulsed LED light of
635 nm (Repuls Lichtmedizintechnik GmbH, Vienna, Austria)
at a pulse rate of 50% and a repetition frequency of 2.5 Hz.
After each procedure the animals were kept in their original
cages.
6 weeks after the invasive dental procedure, the animals
were anesthetized with ketamine and xylazine (see above) and
sacrificed. For all groups, the right mandible was removed, dis-
sected free from the covering soft tissue, placed into a formal-
dehyde solution for 3 days for fixation, and embedded in
paraffin for further µCT analysis. The in vivo part of the study
was performed in accordance with the Guidelines of the
National Institute of Health in the USA regarding the care and
use of animals for experimental procedures and with the 2010/
63/EU Directive and was approved by the Animal Welfare
Committee of the University of Szeged, Hungary (V/1639/2013).
In a previous study, we had shown that tooth extraction in
the presence of high dose of chronic ZOL treatment causes
healing disorder in the jawbone in rats, which resembles the
characteristics of BRONJ (ref. 12). These changes were demon-
strated by comparing ZOL- and vehicle-treated groups (n =
10–10 animals) using micro-CT and histological analyses. As a
continuation of this previous study, we tested the effect of
physical therapies with an expanded set of parameters to not
only visualize structural changes but also potential alterations
in the composition of the bone in the affected region. In com-
pliance with the 3R principle of animal experiments, we did
not intend to repeat control groups (referred to as “negative
and positive controls”) in high animal numbers in the present
study, but we used 6–6 animals in the ESWT- and PBMT-
treated groups. The ‘positive control’ group included animals
undergoing tooth extraction plus treatment with ZOL without
any physical therapy, whereas ‘negative controls’ were sub-
jected to an identical procedure except that these animals
received saline as the vehicle of ZOL. Hence, these groups were
indeed independent and were therefore subjected to statistical
analysis accordingly.
µCT
Jawbones were scanned in toto in a SCANCO µCT 50 (SCANCO
Medical AG, Brüttisellen, Switzerland) with 90 kVp, 200 µA
with a 0.5 mm Al filter; 1000 projections per 180° with an inte-
gration time of 500 ms.
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Sample requirements and preparation. Samples were
received embedded in paraffin with a soft tissue layer still
present on the exterior of the bone, preventing the paraffin
from infiltrating into the ROI.
Determination of the specimen position. For the 3D analysis
of the µCT data, a volume of interest (VOI) was defined within
the jawbone: it is the dense bone between the roots from the
most apical piece of bone below the tooth to the tip of the first
root or to where the bone transitions to a more porous mor-
phology (about 1 mm3). After the µCT scans and the identifi-
cation of the VOI for each jawbone, the bone was then cut with
a band saw (300CP, EXAKT Apparatebau, Norderstedt,
Germany) through the center of the VOI, revealing a bone
surface, which lies inside the µCT VOI. This cut through the
µCT VOI defined the region of interest (ROI) that was analyzed
in 2D by the subsequent imaging modalities. In plane, the ROI
is limited by the 4 roots (the bone surface of the periodontal
ligament space) and between the roots by a straight line at the
narrowest point between adjacent roots (about 750 × 1000 µm).
To ensure proper cutting, the cutting plane was positioned in
a 3D rendering of the µCT reconstruction and then transferred
to the physical sample. The band saw is equipped with a laser
that indicates the cutting line. By comparing this cutting line
with where the plane intersects the 3D model, it is possible to
accurately position the cut. Two parallel cuts were performed
with a distance of 3 mm, resulting in a 3 mm thick slice of the
jawbone that was analyzed further using the subsequent mod-
alities. A region of interest (ROI) was defined on the surface of
this jawbone slice within the VOI and subsequently assessed
in 2D by µXRF, AFM and SEM. The images shown in Fig. 5
were passed on to the subsequent modalities to facilitate the
re-identification of the ROI on the cut samples.
Resolution. Scans were reconstructed to an isotropic resolu-
tion of 17.2 µm.
Data analysis. Measurements were performed within the
VOI using the open-source image processing package ImageJ2/
FIJI (https://imagej.net/Fiji).34–36 Scans were rotated so that the
dentin-enamel junction (DEJ) lied parallel to the XY plane and
the teeth were aligned along the Y axis. The VOI was drawn
between the roots of the first molar using the polygon tool and
interpolation tools. Negative controls were measured at the
third molar. The VOI was segmented with a threshold of
750 mgHA cm−3, and the bone volume, tissue volume and
pore sizes were measured using the BoneJ plugin (v.1.3.11).38
The distance of the alveolar bone crest to the DEJ (bone-to-
enamel distance) was measured using Amira 5.4.7 (Thermo
Fischer Scientific, Waltham, MA, USA). A dynamic slice was
placed through the center of the mesial and distal roots and
the center of the crown of the first molar. The bone-to-enamel
distance was measured at three parallel positions: at the center
of the distal root and in the middle between the center and
the buccal and lingual edge of the distal root.
µXRF
µXRF imaging was performed using the laboratory setup at TU
Wien, Atominstitut; the detailed description of the in-house-built
μXRF spectrometer can be found elsewhere.37 The instrument is
equipped with a Rh-anode low power X-ray tube, and a Si(Li)
detector (active area 30 mm2, LN2-cooled) with an ultrathin
polymer window to allow the measurement of the low energy fluo-
rescence radiation emitted by light elements. The primary beam
was focused by a polycapillary optic (full lens) into a micro-beam
with the size of 50 × 50 μm2 at Cu-Kα (determined using a stan-
dard test sample). For all samples, the tube voltage and current
were set to 50 kV and 0.4 mA, respectively. All measurements were
performed in vacuum, and, for all scans of the ROI, the step size
was 50 μm and measurement time 60 s per point.
Sample requirements and preparation. The cut jawbone was
fixed onto an Al-frame metal plate and positioned vertically in
the spectrometer chamber using a magnetic stage, so that the
standard geometry of 45° between the incident radiation beam
and the sample, and 90° between the incident beam and the
detector is maintained.
Determination of the specimen position. Using a light
microscope (Olympus Highlight 3100, Hamburg) integrated in the
µXRF setup, the ROI was identified and corner points of the area
to be scanned were determined. The ROI spanned about 750 ×
1000 µm2. Once the corner points had been set, the ROI was
scanned with a step size of 50 μm and a dwell time of 60 s, lasting
between 5 to 7 hours. In addition, the roots delineating the ROI
were clearly distinguishable in the µXRF scans due to their low
signals for all three elements (Ca, P, Zn) (compare Fig. 6A).
Resolution. The resolution of 50 µm (corresponding to the
beam diameter and step size) was determined by scanning a





, where d is the wire
diameter – see ref. 37 for further details. Using the mass
Fig. 3 Scheme of the study design. On the first week, chronic intrave-
nous BIS treatment was initiated in 3 groups of animals, whereas the first
group received a saline vehicle; this protocol was continued on every
week. On week 3, the first and second molar teeth from the right man-
dibula were extracted (see X marked in red) in all of the groups. On the
day of tooth extraction, a single event of a local ESWT treatment was
performed in the third group, whereas in case of the fourth group, local
PBM treatment was performed on the day of tooth extraction which was
followed by additional 7 treatments every second day. Mandibles were
harvested at the end of the protocol (6 weeks after the teeth were
extracted) and processed according to the different imaging protocols.
The first group is the negative control group since the animals only
received saline solution intravenously. The second group is the positive
control group and was treated with ZOL without any therapy.
Analyst Paper
























































































attenuation coefficients (μρ) for cortical bone from the
National Institute of Standards and Technology (https://
physics.nist.gov/PhysRefData/XrayMassCoef/ComTab/bone.html)
and a theoretical density (ρ) for hydroxyapatite of 3.16 g cm−3,
one can estimate the information depth for various elements
in bone (e.g. Ca-K: 24 μm, Zn-K: 60 μm).
Data analysis. The fitting of the spectra was necessary to
subtract the background and to ensure that the presented
results corrected for sum or pile-up peaks. QXAS-AXIL38 was
used for deconvolution, and elemental maps of calcium, phos-
phorus and zinc were prepared with LP-map software (Fig. 6A).
Using Fiji, based on their signal counts, elemental distri-
butions were then measured and normalized to the scanned
ROI excluding holes and microfractures as determined by SEM
analysis. The μXRF concentrations were quantified using the
sensitivity values obtained via the measurements of IAEA
animal bone (H5) certified reference material; details can be
found here.39
AFM
The Young’s modulus was determined using nanoindentation
with a JPK nanowizard 3 instrument (JPK BioAFM Business,
Berlin, Germany). The used measurement mode (JPK’s QI-
mode) enabled topographical imaging and determination of
the elastic properties simultaneously. Cantilevers with
diamond-like carbon tip coating (PPP-NCHR, k = 42 N m−1,
f0 = 336 kHz, NanoWorld, Switzerland) were used. The
maximum indentation force was set to 20 μN. The z-length of
sampling was determined as 2 μm and the piezo driving rate
was set to 40 nm ms−1.
Sample requirements and preparation. Before measuring,
samples were cleaned with ethanol and distilled water to
remove embedded paraffin residues (which would lead to
strong interactions between the measuring tip and sample).
Measurements were performed in phosphate buffered saline
(PBS) at room temperature. Bone pieces were fixed to micro-
scope glass slides (VWR, Austria) with a two-component
adhesive (Z-Dupe – Shore-A20, Henry-Schein, Austria) for easy
removal afterwards.
Another requirement for AFM indentation measurements is
the nanoscopic flatness of the samples. Since the measuring
tip can be located at a maximum distance of 15 µm from the
sample surface (restriction/movement possibility of the piezo),
the samples must have a roughness below ∼10 µm – which
was achieved by the clear bandsaw cut as described above.
Determination of the specimen position. Re-identification
of the ROI was facilitated by a combined and fully synchro-
nized single molecule sensitive fluorescence and atomic force
microscope: a JPK nanowizard 3 instrument (JPK BioAFM
Business, Berlin, Germany) was placed on top of the JPK
Motorized precision stage (Brucker, Berlin) that is mounted on
a Zeiss Observer Z1 epifluorescence microscope body. The
combined microscope is placed on a passive anti-vibration
table without additional active damping (Newport). For
experiments, the cantilever was first aligned to the optical
axis via the XY positioning unit on the motorized JPK
precision stage. The two instruments were synchronized via
TTL signals.
Measurements were carried out on at least three samples of
each treatment group within the same ROI as defined for
µXRF and SEM (compare Fig. 4). Depending on the surface
roughness, one (256 × 256 pixels, 65 536 data points) or two
measurements (128 × 128 pixels, 16 384 data points) were per-
formed for each sample on an area of 90 × 90 μm2 inside the
ROI. Within each ROI, three to six 90 × 90 μm2 areas were
scanned.
Resolution. Force curves were recorded for each pixel in an
area of 90 × 90 μm2, resulting in a lateral spatial resolution of
about 700 nm for acquisitions of 128 × 128 pixels and of about
350 nm for acquisitions of 256 × 256 pixels. The penetration
depth results from the indentation depth which ranged from
2 nm up to 8 nm (compare Fig. 4). The force resolution
depends on the system. In our system, the noise was smaller
than 6 pN.
Data analysis. Fitting of the Oliver-Pharr model to the QI
data and determination of the Young’s modulus were achieved
using the batch processing interface of the JPK SPM data pro-
cessing software.40,60 The model predicts the depth of indenta-
tion (according to the tip geometry) and gives the Young’s
modulus for each curve. For each pixel, a single force curve
was collected, resulting in up to ∼65 000 data points per 90 ×
90 μm2 area. The Young’s modulus per sample is given as an
average of these data points with three to six scanned 90 ×
90 μm2 areas per ROI. Fig. 4 shows a representative force dis-
tance (indentation) curve together with the fitted model and
extracted value.
SEM
Samples were examined with a Hitachi TM-1000 tabletop scan-
ning electron microscope operated at 15 kV and equipped with
a high-sensitive semiconductor backscattered electron
detector.
Sample requirements and preparation. The samples were
rinsed with distilled water to remove potential phosphate resi-
dues from PBS (used in AFM measurements). Samples were
sputtered with a 4 nm gold layer in a Balzers SCD 050.
Determination of the specimen position. Due to the clear
visibility of the roots in the backscattered electron channel,
the roots could be used as landmarks with a clear delineation
of the ROI. The same ROI as for µXRF of about 750 × 1000 µm2
was scanned.
Resolution. The pixel size for the highest magnification was
800 nm and corresponds to the lateral resolution.
Data analysis. Fiji was used to analyze the average microfrac-
ture size and microfracture density of the samples. Each micro-
fracture within the same ROI as for the other modalities was
marked by freehand selection, and its area was measured
(Fig. 7A). The threshold to analyze the average microfracture
size was set to above 10 μm2 to exclude minimal lesions or
cracks. Using Fiji, the percentage of microcracks within the
ROI (microfracture density) and the average crack size in the
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ROI were determined and compared across the 4 different
groups.
Data analysis
Analysis of the acquired images was carried out as described
in the Experimental section of each modality to obtain a para-
meter cloud per sample group.
For the comparison of the measured parameters across the
different groups, we explored the data by employing the stat-
istical computing software environment R v3.6.3.41 The data
were plotted in boxplots using the packages ggplot2 (https://
CRAN.R-project.org/package=ggplot2) and ggpubr (https://
CRAN.R-project.org/package=ggpubr). A one-way analysis of
variance (ANOVA) was conducted to analyze differences in the
mean values between the four groups (PBMT, ESWT, Neg-Ctrl
and Pos-Ctrl). We checked for normality using the Shapiro–
Wilk-test and tested for homogeneity of variances using the
Levene-test (package “car”, https://CRAN.R-project.org/
package=car). Due to non-normality, a non-parametric
Kruskal–Wallis-test with a further Dunn-test with Bonferroni
correction (package “dunn.test”, https://CRAN.R-project.org/
package=paran) was conducted for Zinc, microfracture size,
microfracture density and pore thickness. The significance
level was set at 0.05.42
For the comparison of all acquired parameters per ROI
independent of their group, a correlation matrix was produced
using the package stats v3.6.3 and visualized using the
package corrplot v0.84.43 Due to unequal sample sizes in the
four variables PBMT, ESWT, Neg-Ctrl and Pos-Ctrl we applied a
pairwise deletion for missing data treatment. Since the
missing values are not related to the other variables in the
data set (missing completely at random) and the proportion of
missing data did not exceed 20%, pairwise deletion can be
considered as an appropriate technique.44 The numerical cor-
relation coefficients of the correlation matrix can be found in
the ESI (Table S2†).
Results & discussion
The showcased CMI pipeline comprised four complementary
modalities: µCT, µXRF, AFM and SEM. Each modality contribu-
ted a different length scale or biophysical parameter to the
characterization of the jawbone. Mechanical information on
the stiffness of the jawbone and chemical information on the
elemental composition were contributed by AFM and µXRF
and complemented the imaging modalities that typically
assess morphology (µCT and SEM). The combined imaging
modalities were chosen such that they complemented each
other while still ensuring compatibility concerning the sample
preparation workflow. SEM and AFM achieved the highest
resolution but required sectioning of the bone, µCT achieved
modest resolution in comparison to SEM but allowed to image
the entire intact bone and provided overall context, and µXRF
hardly gave structural context but added otherwise inaccessible
information about the elemental composition.
The established CMI workflow is illustrated in Fig. 4: we
distinguish between the VOI for µCT (about 1 mm3) as the
only imaging technology that assessed the jawbone in 3D and
the ROI of about 750 × 1000 µm for all subsequent techno-
logies that only assessed the 2D topography of a cut section
within the VOI of the jawbone. The VOI for µCT is located
below the first molar (see Fig. 5) and indicates the volume in
which the bone parameters were measured (in 3D): two of the
three molars were extracted in each sample. Around the extrac-
tion sites, the bone exhibited highly irregular changes with
large differences between all samples and occasional tooth
fragments still embedded in the bone. This made the choice
of a robust VOI difficult. For this reason, the dense homo-
geneous bone between the roots of the intact molar was
chosen as VOI (from the most apical piece of bone below the
tooth to the tip of the first root or to where the bone tran-
sitions into a more porous morphology). Changes at this site
were less severe than at the extraction site but, due to its proxi-
mity, this region had received doses of ESWT and PBMT
similar to those of the extraction site itself. The sample was
then cut with a band saw through the center of the VOI, reveal-
ing a bone surface (ROI), which lay inside the µCT VOI
(compare Fig. 4 and Experimental). For all subsequent modal-
ities, measurements were performed within this ROI, which
was limited in 2D by the four roots and by a straight line at the
narrowest point between adjacent roots. Re-identification of
this ROI after relocation between the modalities was facilitated
by (i) the integration of light microscopes into the µXRF and
AFM platforms and by (ii) its delineation by the four roots that
were clearly visible in µXRF and SEM (see Fig. 6 and 7). µXRF
and SEM scanned the entire ROI for each sample, whereas
AFM measurements were limited to at least three selected
areas of 90 × 90 µm2 within the ROI due its nanometer pre-
cision and long measuring time per pixel (Fig. 4).
To facilitate correlation of the data across modalities, we
scanned the same ROI of about 1000 × 750 µm2 of each
sample sequentially and without compromising data quality.
With correlation, we refer to identifying this ROI of a single
sample after relocation between imaging platforms, including
the quantification of (averaged) values from the ROI and their
comparison both across differently treated groups and modal-
ities. We did not co-register the data pixelwise. Since, based on
the µCT reconstructions, the ROI was chosen such that it
covered only homogeneous dense bone, it was sufficient to
average the information obtained from the ROI (such as
elemental concentrations and mechanical stiffness) and
compare it across modalities. We nevertheless required precise
imaging technologies to ensure that measurements were only
taken from within the clearly delineated ROI. In addition, a
pixelwise correlation would be hampered by the large
differences in pixel size across modalities (for AFM and µXRF,
for example, the pixel size was 350 nm and 50 µm,
respectively).
On the macroscopic scale, we used ex vivo µCT to visualize
the entire intact jawbone of several millimeters in thickness
and the contextual morphology at an isotropic resolution of
Analyst Paper
























































































17.2 μm. µCT provided quantitative 3D information about the
local dense bone morphology within the VOI as described in
the Experimental section (Fig. 5). The non-destructive
measurements of µCT made it possible to choose an appropri-
ate plane within the VOI (ROI) for further 2D investigation
using µXRF, AFM and SEM.
Within the µCT VOI, the bone volume fraction (bone-to-
tissue volume (BV/TV)) and pore sizes were measured. The
bone volume fraction describes the volume of mineralized
bone per unit volume of the sample; the threshold was set to
750 mg cm−3 hydroxyapatite. The bone volume fraction is
expected to decrease and the pore size to increase in necrotic
Fig. 5 Selection of the 3D VOI based on the µCT scan of a negative control sample. (A) View of the extracted piece of jaw from the lingual side.
Tooth extraction site circled in green; first molar highlighted in yellow. (B) View from coronal side. (C, D) Cut-through center of the first molar from
lingual (C) and mesial (D) sides; VOI highlighted in red. (E–G) Horizontal cuts through the VOI at the top, center and bottom layer of the VOI.
Fig. 4 Synopsis of the CMI workflow to visualize multiparametric jawbone features for the clinically relevant murine model of BRONJ before and
after treatment with BISs, ESWT and PBMT. The modalities were applied sequentially. Textboxes below the modality name indicate the measured
bone parameters for each technology (i.e., morphology, elemental concentrations, mechanical stiffness, and topography). The color code is based
on Fig. 2A. The images from the single modalities indicate in red the VOI for µCT and the ROI for µXRF/SEM and AFM. The texts below the images
specify the scanned VOI and ROI and show the achieved resolution in parentheses: the entire jawbone was scanned in 3D at 17.2 µm resolution
using µCT, and a VOI of about 1 mm3 was defined based on the µCT reconstruction to analyze the bone morphology, including the bone volume
fraction and pore thicknesses. The jawbone was cut through the center of the VOI, and the cut surface was further analyzed in 2D using µXRF, AFM
and SEM. Based on the VOI, the ROI for µXRF and SEM was defined (indicated in red) and is delineated by the four roots of the first molar tooth. For
µXRF, the elemental concentrations for each sample were averaged across this ROI. For AFM, from within the ROI, at least three areas of 90 ×
90 µm2 (blue squares in the brightfield image) were selected and scanned to acquire topography and Young’s moduli (up to 65.000 data points).
One data point was recorded within each pixel (green square), and all data points across the 90 × 90 µm2 areas within one ROI were then averaged
to yield the Young’s modulus for the sample. The right image under AFM shows a representative indention curve, acquired within one pixel. The
x-axis reflects the nanoscopic movement of the measuring tip in the direction towards the sample surface. Once the probe tip has deformed the
surface, the probe tip experiences linear bending with force. The region between the first contact and the linear bending specifies the indentation
depth that corresponds to the penetration depth.
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bones. The distance between the alveolar crest and the DEJ
(bone-to-enamel distance) was measured on the intact molar
on the side adjacent to the extraction for at least four data
points per sample. The distance is assumed to increase in
cases of disturbed homeostasis and misbalances of the bone
tissue as a result of alveolar bone loss.45
For cross-modality imaging, the information from the µCT
scans was then used to cut each sample through the center of
the VOI at exactly the same position and angle as explained in
the Experimental section. As the VOI was only around 1 mm3
in volume, sectioning had to be accomplished at high pre-
cision using a diamond-coated band saw since the other mod-
alities depended on a highly reproducible cut and a low rough-
ness of below 10 µm to enable the combination of the modal-
ities on a single sample. Without the information from the
µCT to plan the sectioning, this would not have been possible
with the required precision. After cutting, the pictures in Fig. 5
were created and passed along to subsequent modalities to
ease identification of the ROI for subsequent modalities.
The macroscopic information for each VOI was then com-
plemented by measurements of the elemental composition
within the 2D ROI at a pixel size of about 50 μm using µXRF
(Fig. 6A). Elemental maps were obtained by raster-scanning
the jawbone ROI surface. The spatial resolution depended on
the size of the X-ray beam. In this setup, the beam was focused
to a size of 50 μm, therefore, the lateral resolution is in the
same range (compare Experimental). The final elemental con-
centrations per sample were averaged across the ROI. The
depth resolution (penetration depth) is element dependent.
Further information on the method can be found in ref. 46.
µXRF allowed the semi-quantitative assessment of the
sample: within each spectrum (obtained from a single scan
point), the area under the peak of the element of interest was
estimated by the software and translated into counts. The
calcium, phosphorus and zinc levels were assessed by measur-
ing the mean signal intensity in the ROI of their corres-
ponding elemental maps and translated into concentrations
using standard reference material (see Experimental).
Examples of calcium, phosphorus and zinc maps are shown in
Fig. 6A. This is the same sample as shown in Fig. 5 (µCT), 6B
(AFM) and 7 (SEM) and indicates the same ROI (dashed red
line) across modalities. Phosphorus and calcium are the two
major constituents of hydroxyapatite (Ca10(PO4)6(OH)2), the
primary bone component. Due to their occurrence in hydroxy-
apatite, both elemental maps of calcium and phosphorus are
expected to show the same trends. Zinc and strontium are the
trace elements that are normally found in bone tissue.47 Zinc
acts in many ways on the formation and remodelling of bone
tissue. On the molecular basis, it stimulates alkaline phospha-
tase (ALP) activity, resulting in an increased mineralization
process.48 For necrotic bones, a decrease in calcium and phos-
phorus levels is expected since a lower bone mineral density is
thought to be directly related to lower hydroxyapatite levels.
However, osteonecrosis is a localized phenomenon which may
occur only at some portions of the tooth extraction site in
response to BIS. Conversely, BIS per se increases the mineral
density in the bone (at the tooth extraction site and also in
most of the bones of the body), since BISs suppress osteoclasts
and slow the remodelling process while they can still induce
BRONJ as a severe side effect.6
Fig. 6 AFM and µXRF of the same sample as shown in Fig. 5 and 4 for a truly correlative approach. (A) µXRF elemental distributions showing
calcium (left), phosphorus (middle) and zinc (right) maps (in counts). The ROI is delineated by the red dashed lines. The legend to the right of each
image shows the pixel intensity. Purple areas (low pixel intensity) mainly correspond to the non-mineralized tissue around the teeth roots. Scale
bars: 200 µm. (B) AFM nanoindentation measurements show the sample topography (left) and the distribution of Young’s moduli (right) in a fraction
from within the ROI as explained above (a selected area of 90 × 90 µm2). This area is indicated in the phosphorus map (red square). This 90 ×
90 µm2 area was scanned by AFM (as indicated by the dashed red lines) to simultaneously measure topography and Young’s modulus, using JPK QI
mode. Representative data are shown for the same negative control sample of Fig. 5 and 7. Young’s moduli (in GPa) were calculated using the Oliver
Pharr model.
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µXRF was shown to be an ideal modality for correlative
imaging and this CMI pipeline in particular. Re-identification
of the ROI was achieved using the attached light microscope at
the µXRF setup (compare Experimental). Due to its clear deli-
neation by the four roots, the ROI could be unambiguously
detected. The advantage of µXRF over other elemental imaging
techniques (e.g. secondary ion mass spectrometry, laser abla-
tion inductively coupled mass spectrometry) is its non-destruc-
tiveness, which facilitates the combination with other imaging
modalities.49–51 In addition, µXRF provided the necessary
spatial resolution to precisely delineate the ROI and only
measure within this region. µXRF has rather straightforward
requirements in terms of sample preparation: flat smooth sur-
faces, and, in the case of non-confocal µXRF (as applied in the
current project), thin samples are preferred to minimize the
influence of element-dependent information depth. In most
cases, preliminary embedding is performed since embedding
preserves the tissues, aids in cutting/polishing, and a portion
of the embedding medium around the tissue helps to main-
tain the shape of a thin section and facilitates its mounting on
the sample stage. The paraffin embedding of the jawbones
was, therefore, well-fitting to the requirements of µXRF. For
the subsequent modalities after µCT (see Fig. 4), paraffin-
embedded jawbone sections were warmed up to +60 °C in an
embedding station to remove paraffin.
All structural and elemental data were complemented by
mechanical parameters that assessed the stiffness within the
ROI (Young’s modulus) using AFM, as described in
Experimental. While the sample was scanned at submicrom-
eter resolution, a single Young’s Modulus was given for each
sample and used for comparison since it was averaged across
the scanned areas of about 90 × 90 µm2 from within the ROI of
homogeneous dense bone tissue (see Fig. 4 and 6). To deter-
mine the stiffness and elastic properties of the jawbones, we
measured the Young’s modulus using AFM-nanoindentation
(see Experimental). AFM nanoindentation uses a cantilever
with a characterized tip geometry as indenter, which allowed
for a high spatial resolution in the nanometer range. For the
determination of the Young’s modulus, the measured force
data were fitted with the Oliver Pharr model (see
Experimental).
The values for the Young’s moduli varied from a few tenths
of GPa to up to 5 GPa for a single area of 90 × 90 µm2 within
the ROI, depending on the location of the measurement
(Fig. 6B, right). Although the ROI was chosen to be as homo-
geneous as possible, this might also be due to the different
layers of bone tissue which provide different mechanical
strengths. While the cortical bone, for example, needs to with-
stand daily compression and is therefore stiff, the trabecular
bone (also called spongy bone) hosts blood vessels and
bone nerves and has a lower Young’s modulus. For the rat
mandibulae, a Young’s modulus of about 3 GPa had
been measured previously.52 For necrotic bones and increased
porosity, we expected a decreased mechanical stiffness; for
higher bone mineral density, we expected higher Young’s
moduli.53
For cross-modality imaging using AFM, paraffin was
removed after µXRF imaging, and the cut jawbones were
additionally washed with Ethanol to remove potential paraffin
remains and minimize background noise. This was followed
by moistening the samples with PBS. With the AFM-attached
light microscope (see Experimental), the ROI was identified
based on its delineation by the tooth roots. Importantly,
similar to the other combined modalities, AFM does not need
staining or labeling of features of interest, which facilitated
cross-modality imaging.
On the microscopic scale, the topography of the cut
jawbone was visualized using SEM at a resolution of about
800 nm. This resolution allowed to identify and measure
microfractures in the ROI. Microfractures are a typical patho-
physiological indication of BRONJ due to bone loss and
destruction. Assuming that BIS-treated animals will exhibit
more microfractures, we used SEM to determine the density
and area of microfractures (Fig. 7). We quantified two para-
meters: (i) microfractures density within the ROI, and (ii) the
average microfracture size. In contrast to the pore thicknesses
assessed by µCT, the average microfracture size is measured in
2D at higher resolution. µCT pores were, in principle, only
detectable in 2D if spanning at least two pixels (i.e., at least
300 µm2 for a pixel size of 17.2 µm), whereas microfractures
were unambiguously identified and discerned above a size of
about 10 µm2 (which we set as the minimal threshold after
data analysis).
For cross-modality compatibility, as shown in Fig. 4, SEM
was applied as the last imaging modality of the established
CMI pipeline since it required a thin gold coating to counteract
electrical charging – the coating would have hindered AFM
measurements.
Novel CMI pipelines (including more than two modalities)
are still in their infancy since they require considerable
method development due to the lack of commercially available
implementations. CMI faces several challenges: (1) preparation
steps for one imaging technique are often incompatible with
those of another, (2) workflows and markers are missing that
facilitate tracking and correlation of ROIs after relocation
between imaging platforms, (3) many advanced imaging tech-
niques might simply not be available or accessible to a single
researcher,61 and (4) CMI requires a broad expertise to oversee
several modalities.32 Our CMI pipeline required substantial
coordination and careful sample preparation procedures that
were compatible across all modalities without compromising
data quality (including the sequence of experiments). Main
points to take into consideration included a flat cut of the
jawbone after µCT for all the subsequent imaging modalities
(AFM specifically required a sample roughness of below
∼10 µm), removal of paraffin after µXRF for the AFM measure-
ments, and a thin gold coating before SEM. The precise
selection of the VOI and ROI was enabled by µCT and flat
band saw cuts. For µXRF and AFM, the subsequent re-identifi-
cation of the 2D ROI on cut sections was possible due to their
integrated light microscopes in hybrid setups. In addition, the
identification of the ROI was facilitated across modalities due
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to its delineation by the roots that produced a clearly dis-
cernible signal across different contrast mechanisms in SEM,
µXRF and light microscopy as integrated in the AFM setup
(Fig. 5–7).
In addition, the established CMI pipeline provided us with
a versatile tool to (a) characterize BIS-treated jawbones in com-
parison to untreated tissue, (b) assess the effects of physical
PBMT and ESWT in terms of morphology, elemental compo-
sition and stiffness after BIS treatment, and (c) establish inter-
dependencies between all measured parameters across
modalities:
(a) Although differences between the untreated negative
control group and BIS-treated groups were observed across all
modalities (compare Table 1 and Fig. 8), the differences were
not shown to be significant, which could be due to the small
sample size of only up to 5 samples per group. In our study,
the data nevertheless indicated clear trends of the averaged
parameter values across groups and provided useful additions
to the observed mucosal healing disorders and discontinuity
of the cortical and spongious bone regions in the mandible of
treated versus untreated groups, observed in our previous study
on this clinically relevant rat model of BRONJ.12
In terms of morphological parameters, we observed a
decrease in the average pore thickness, microfracture size and
bone-to-enamel distance in all BIS-treated groups compared to
the negative control, while, at the same time, the average
microfracture density increased for all BIS-treated groups.
There was a trend towards a higher bone fraction volume after
BIS treatments. BIS-treated samples, independent of the physi-
cal therapies they received, seem to be more prone to the
Fig. 7 (A) Overview SEM image at ×80 magnification of exactly the same sample and ROI as selected by µCT. The rectangle marks the ROI. To the
right the ROI is shown at 200× magnification – including the counted microfractures. (B) SEM images of the ROI at a magnification of ×200. (i) Non-
treated jawbone of the negative control group, (ii) BIS-treated animals of the positive control group, (iii) ESWT animals, and (iv) PBMT animals.
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accumulation of small-sized microfractures, which, in turn,
reduces the average values for the measured pore and micro-
fracture sizes. It was found previously in animal studies that
BIS could increase the microdamage frequency in a dose-
dependent manner, caused by excessively suppressed bone
turnover.33 The accumulation of microfractures might contrib-
ute to the deterioration of the biomechanical bone integrity
and contribute to the onset of BRONJ. Contrary to expec-
tations, the negative control group exhibited a large bone-to-
enamel distance. However, samples with residual root frag-
ments directly adjacent to the measurement site were
excluded, leaving only a single sample for the negative control
group, which is why further analysis and correlation of more
samples will be needed to draw definite conclusions.
In our study, the accumulation of microfractures was
accompanied by a decrease in the mechanical stiffness of the
jawbones. On average, BIS-treated samples exhibited lower
Young’s moduli compared to the untreated control group. The
stiffness of bone was found previously to be highly dependent
on its porosity, and Young’s moduli decrease nonlinearly with
increasing pore densities.53
While the increase in microfracture densities after BIS treat-
ment hints towards reduced mechanical and physiological
bone integrity that might be prone to BRONJ, in terms of
elemental composition, on average, all measured concen-
trations of calcium, phosphorus, and zinc increased after BIS
treatment and indicated increased bone stability. Increased
calcium and phosphorus concentrations are in line with the
expectations for BIS treatment since BISs, per se, increase bone
mineral density ubiquitously as they accelerate osteoclast
apoptosis and inhibit bone resorption.6,54 Zinc deficiency was
shown to be associated with bone growth retardation, and an
increase in zinc concentrations might be beneficial for the
development, growth, and health of the bone.55,56
(b) Our results did not indicate that the applied PBMT or
ESWT influenced bone alterations considerably concerning
the mechanical and elemental composition since the
measured parameters of these groups did not change signifi-
cantly compared to the BIS-treated positive controls that did
not receive physical therapies (Fig. 7). However, ESWT and
PBMT exhibited a trend towards smaller pore thicknesses com-
pared to the negative control (Kruskal–Wallis chi-squared =
10.329, df = 3, p-value = 0.016), which might be due to the
overall increase in microfracture densities after BIS treatment.
The differences in pore thickness were significant between
PBMT and the negative control (Post-hoc Dunn, p = 0.007). In
terms of bone-to-enamel distance, both the ESWT and PBMT
group revealed notably smaller averaged values as compared to
the positive and negative control groups (ANOVA, F = 10.86, df
= 3, p = 0.003) – a hint for improved homeostasis and alveolar
bone turnover after the physical therapies. The differences
were significant between ESWT and the positive (Post-hoc
Tukey, p = 0.021) and negative control (Post-hoc Tukey, p =
0.006), as well as between PBMT and the negative control (Post-
hoc Tukey, p = 0.013). Since zinc plays a critical role in numer-


















































































































































































































































































































































































































































































microstructural stability and bone remodeling, these findings
are also in line with the tendency of increased zinc concen-
trations after both ESWT and PBMT (Table 1).
(c) The novel pipeline allowed to establish interdependen-
cies between the different morphological, topographical,
elemental and mechanical parameters that had been analyzed
by the 4 modalities. These correlations were assessed indepen-
dent of the group: since each ROI was measured by each
modality and probed for each of the parameters shown in
Fig. 8 and Table 1, the showcased CMI pipeline allowed to
establish correlations from within the same area of a single
specimen. Correlations are shown in the correlation matrix of
Fig. 9, and the corresponding correlation coefficients are given
in Table S2.† We observed both cross-modality and inner-
modality interdependencies. As can be appreciated in Fig. 9,
in our study, the Young’s modulus as measured by AFM corre-
lated positively with the average microfracture size and pore
thickness, but negatively with the elemental concentrations as
measured by µXRF and with the microfracture density as
probed by SEM: the smaller the average microfracture size and
pore thickness, the lower the Young’s modulus; the higher the
microfracture density and the elemental concentrations, the
lower the stiffness of the bone. This is in line with our findings
in (a) – and reveals two unexpected trends: (1) a positive corre-
lation between pore size and mechanical stiffness; (2) a weak
negative correlation between mineral density and mechanical
stiffness (compare Fig. 9). As pointed out in (a), the first corre-
lation can be explained by the assumption that a decrease in
the average pore and microfracture size is due to the increase
in the amount of small-sized microfractures after BIS treat-
ment and a corresponding higher microfracture density, i.e. a
lower mechanical stiffness correlates with smaller pore sizes
Fig. 8 Measured parameter sets per modality to characterize jawbones across the different groups. (A) Pore thickness, bone-to-enamel distance
and bone volume fraction (BV/TV) as quantified by µCT. No significant difference was observed between BIS-treated samples and negative controls,
but a consistent tendency of the BIS-treated bones for higher BV/TV average values, and smaller average pore thickness. The ESWT values of bone-
to-enamel-distances differed significantly in comparison to the negative (p = 0.006) and positive control (0.021), as well as the PBMT values in com-
parison to the negative control (0.013). For the pore thickness, the difference between the PBMT group and the negative control was shown to be
significant (p = 0.007). (B) Calcium, phosphorus and zinc concentrations as assessed by µXRF. As expected, calcium and phosphorus concentrations
show the same trends due to their occurrence in hydroxyapatite. On average, all BIS-treated jawbones show increased calcium, phosphorus and
zinc concentrations as compared to the negative control group. (C) Young’s modulus measured by AFM. The graph shows the mechanical stiffness
of bone samples. On average, the stiffness decreased for BIS-treated jawbones. (D) Average microfracture size and microfracture density as assessed
by SEM. Despite no significant differences, a tendency can be observed: all BIS-treated animals exhibit a higher average microfracture density with
on average smaller microfracture sizes as compared to the negative control group (compare also Table 1). For all boxplots, the median is given as a
line in the box. The boxes themselves comprise the interquartile range (lower to upper quartile); the whiskers show the minimum and the maximum.
Outliers are indicated as points.
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due to a higher microfracture density. A possible explanation
for the second correlation for the decrease in mechanical
stiffness despite the BIS-induced increase in mineral densities
(Ca/P/Zn) can be the destabilizing effects of the simultaneous
microfracture accumulations.53 In addition, the average micro-
fracture size as measured by SEM correlated positively with the
bone-to-enamel distance as assessed by µCT.
Within the parameter clouds assessed by a single modality,
positive correlation was revealed among elemental concen-
trations of zinc, calcium and phosphorus. This is only logical
since phosphorus and calcium are the two major constituents
of hydroxyapatite (Ca10(PO4)6(OH)2), the primary bone com-
ponent, and zinc can occur in the mineral component, prob-
ably in hydroxyapatite or in complex with fluoride, which
might improve the crystallinity of apatite.56 Negative corre-
lation was revealed among the CT parameters and is also little
surprising: the bigger the measured pore thickness, the
smaller will be the bone volume fraction. Interestingly, we did
not find significant correlations between elemental distri-
butions and the morphology of the bone (microfractures,
porosity or bone volume fraction) – except for a weak
negative correlation between zinc concentrations and pore
thicknesses.
Conclusion
The aim of this project was to showcase the feasibility and
compatibility of a CMI pipeline across modalities for measur-
ing and comparing diverse jawbone parameters (morphology,
mechanical stiffness, elemental concentrations) before and
after treatments with BIS and physical therapies. With the
established imaging pipeline, current limitations of the single
modalities (i.e. the restriction of each technique to only one
resolution and information space) were overcome due to the
complementary combination of the modalities. Each tech-
nique contributed unique parameters to the characterization
of treated and untreated jawbones according to its strengths.
While ex vivo µCT represented a good tradeoff between high
resolution and broad field of view (the entire 3D morphology
of the jawbone), it did not provide physical or chemical para-
meters. Biophysical characteristics (the stiffness of the
jawbone as quantified by the Young’s modulus) were provided
by AFM in 2D and complemented by the 2D assessment of the
elemental composition (calcium, phosphorus, and zinc con-
centrations) of each jawbone by µXRF. SEM zoomed in onto
the surface of the cut jawbone and characterized the topogra-
phy (microfractures) at (sub)micrometer resolution. The pipe-
Fig. 9 Correlation matrix of morphological, mechanical and elemental properties. Interdependencies of parameters from within the same ROI inde-
pendent of their group can be established both across modalities and within a modality dataset. Blue circles indicate a positive, red circles a negative
correlation. Circle size and color scheme correspond to the correlation coefficient (dark color and big circles correspond to highly correlated, light
color and small circles to uncorrelated data). See also ESI, Table S2.†
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line provides a versatile tool to interrelate biophysical pro-
perties and structure of exactly the same bone and will foster
the integration between multiscale and multimodality data
sets in preclinical bone models. Although CMI promises great
potential in holistically characterizing BIS-treated bones and
diseases in general, it presents several challenges from a tech-
nical point of view that need to be overcome. The routine use
of CMI in biomedical research, including this specific pipe-
line, will need to aim at automation to create statistical
throughput – specifically since the presented pipeline is time-
consuming and needs careful logistics and modified sample
preparation protocols due to the variety of involved modalities.
Specifically, markers, workflows and software are missing that
facilitate tracking and correlating ROIs after relocation
between imaging platforms and allow automated registration
and correlation of different images and parameters of diverse
modalities. While we restricted our analysis to averaged values
from within a well-defined ROI of about 0.75 mm2, pixelwise
co-registrations across modalities (as achieved for example
in57) can yield element-to-tissue correlations at micrometer
accuracy.
In addition to the development of the CMI pipeline, our
approach provided insights into the characteristics of BIS-
treated jawbones and assessed the changes induced by physi-
cal therapies. Using CMI, we integrated a variety of structural
and biophysical information of a single jawbone. Across the 4
different groups, we revealed changes after BIS treatments in
the morphology (pore thickness, bone-to-enamel distance,
microfracture density and average size), stiffness (Young’s
modulus) and elemental composition (calcium, phosphorus
and zinc concentrations) of the jawbone, but the pipeline did
not highlight PBMT or ESWT as physical therapies that had a
significant effect on the measured bone parameters or re-
established untreated characteristics (although ESWT and
PBMT reduced pore thicknesses and bone-to-enamel distances
significantly). Interestingly, the average values for both micro-
fracture densities and calcium, phosphorus and zinc concen-
trations increased consistently after BIS treatment. Across all
samples independent of their treatment and group, the estab-
lished CMI pipeline revealed a variety of interdependencies
between the measured parameters of the modalities. For
example, as pointed out in the results section, in our case, a
decrease in stiffness was accompanied by an increase in the
microfracture density and, surprisingly, an increase in
calcium, phosphorus and zinc concentrations. Further corre-
lation studies are needed to confirm our findings with statisti-
cal significance and to rule out any effect of the fixation with
formaldehyde on mineral content of the bone. For future
studies, this CMI pipeline can be used as a versatile tool for
researchers to assess bone diseases holistically and help to
identify biomarkers in osteonecrosis. CMI will surely be a
routine approach in future biomedical research and diagnos-
tics, once its achievements are showcased in further CMI pipe-
lines, and higher throughput will be facilitated by automation
and easy access to high-end imaging infrastructure and
expertise.
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